Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
A comparative study for the isolation of rabbit phenotypically defined candidate HSPCs based on CD45 or CD34 marker expression
Related
- Identification of candidate selenium-associated transcriptomic biomarkers in chronic obstructive pulmonary disease: an integrated bioinformatics and expression validation study
- Cross-lineage anomaly detection of microRNA expression: a framework for deriving exploratory candidate biomarkers in sarcoma.
- Comparative Discriminative Performance of the HbA1c/HDL-C Ratio, Stress Hyperglycemia Ratio, and ZJU Index for HOMA-IR-Defined Insulin Resistance in Patients With Type 2 Diabetes.
- Expression Characteristics of SERINC1 and TDO2 in Diabetic Kidney Disease: Historical Candidate Reappraisal, Cross-Cohort Evaluation, Single-Cell Analysis, and a Mouse Model Study
- Comparative and Histology-Aware Bioinformatic Characterization of FAM171A1 and FAM171A2 in Sarcoma: Expression, Prognostic, and Immune Associations
BibTeX
@article{vasicek2026comparative,
title = {{A comparative study for the isolation of rabbit phenotypically defined candidate HSPCs based on CD45 or CD34 marker expression}},
author = {Jaromír Vašíček and Miroslav Bauer and Andrej Baláži and Andrea Svoradová and Jakub Vozaf and Lucia Olexiková and Peter Supuka and Andreas Nicodemou and Tomáš Zemánek and Peter Chrenek},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74633-x},
url = {https://www.nature.com/articles/s41598-026-74633-x},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - A comparative study for the isolation of rabbit phenotypically defined candidate HSPCs based on CD45 or CD34 marker expression
AU - Jaromír Vašíček
AU - Miroslav Bauer
AU - Andrej Baláži
AU - Andrea Svoradová
AU - Jakub Vozaf
AU - Lucia Olexiková
AU - Peter Supuka
AU - Andreas Nicodemou
AU - Tomáš Zemánek
AU - Peter Chrenek
PY - 2026
DA - 2026/10/07
JO - Scientific Reports
DO - 10.1038/s41598-026-74633-x
UR - https://www.nature.com/articles/s41598-026-74633-x
SN - 2045-2322
ER -